Technical Analysis for BIO.B - Bio-Rad Laboratories, Inc. Class B

Grade Last Price % Change $ Change
grade A $197.05 0.00% 0.0
BIO.B closed unchanged on Wednesday, March 22, 2017, on 8 percent of normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical BIO.B trend table...

Date Alert Name Type % Chg
Mar 22 Narrow Range Bar Range Contraction 0.00%
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Boomer Buy Setup Bullish Swing Setup 0.00%
Mar 22 Calm After Storm Range Contraction 0.00%
Mar 21 Narrow Range Bar Range Contraction 0.00%
Mar 21 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 21 Boomer Buy Setup Bullish Swing Setup 0.00%
Mar 21 Calm After Storm Range Contraction 0.00%

Older signals for BIO.B ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO.B a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 204.0
52 Week Low 130.9
Average Volume 181
200-Day Moving Average 163.3802
50-Day Moving Average 189.2036
20-Day Moving Average 193.4575
10-Day Moving Average 196.645
Average True Range 1.1878
ADX 42.1
+DI 63.6
-DI: 33.74
Chandelier Exit (Long, 3 ATRs) 200.4366
Chandelier Exit (Short, 3 ATRs) 190.9834
Upper Bollinger Band 202.4632
Lower Bollinger Band 184.4518
Percent B (%b) 0.7
Bandwidth 0.093103